🧬 Japan approved the world's first 2 iPS cell medicines — and researchers are making "universal blood" from stem cells that works for ANY patient, no blood-type matching needed.
20 yrs after Yamanaka's Nobel, iPS Cell 2.0 is here.
#iPSCell #RegenerativeMedicine #StemCells
20 yrs after Yamanaka's Nobel, iPS Cell 2.0 is here.
#iPSCell #RegenerativeMedicine #StemCells
April 5, 2026 at 4:20 PM
🧬 Japan approved the world's first 2 iPS cell medicines — and researchers are making "universal blood" from stem cells that works for ANY patient, no blood-type matching needed.
20 yrs after Yamanaka's Nobel, iPS Cell 2.0 is here.
#iPSCell #RegenerativeMedicine #StemCells
20 yrs after Yamanaka's Nobel, iPS Cell 2.0 is here.
#iPSCell #RegenerativeMedicine #StemCells
Epicardially transplanted allogeneic iPSCell-derived cardiac muscle remuscularizes chronically failing hearts without limiting side effects in rhesus macaques and one patient. An important step toward cardiac cell therapy.
https://buff.ly/41brokE
https://buff.ly/41brokE
February 9, 2025 at 6:53 PM
Epicardially transplanted allogeneic iPSCell-derived cardiac muscle remuscularizes chronically failing hearts without limiting side effects in rhesus macaques and one patient. An important step toward cardiac cell therapy.
https://buff.ly/41brokE
https://buff.ly/41brokE
🫀 Japan plans the WORLD'S FIRST pediatric iPS cell trial for acute liver failure!
Bioartificial liver "UTOpiA" perfuses blood through lab-grown organoids. Animal trials hit 90% survival. Could save kids waiting for transplants.
#iPSCell #Biotech #JapanScience #LiverFailure
Bioartificial liver "UTOpiA" perfuses blood through lab-grown organoids. Animal trials hit 90% survival. Could save kids waiting for transplants.
#iPSCell #Biotech #JapanScience #LiverFailure
May 5, 2026 at 5:38 PM
🫀 Japan plans the WORLD'S FIRST pediatric iPS cell trial for acute liver failure!
Bioartificial liver "UTOpiA" perfuses blood through lab-grown organoids. Animal trials hit 90% survival. Could save kids waiting for transplants.
#iPSCell #Biotech #JapanScience #LiverFailure
Bioartificial liver "UTOpiA" perfuses blood through lab-grown organoids. Animal trials hit 90% survival. Could save kids waiting for transplants.
#iPSCell #Biotech #JapanScience #LiverFailure
